Moderna, Inc. reports $145 million revenue for quarter ended June 30, 2026, up 2.1%

ยท MRNA

Moderna, Inc. reported revenue of $145 million for the quarter ended June 30, 2026, an increase of 2.1% from the same quarter a year earlier ($142 million).

For the same period it posted a net loss of $782 million, or $-1.97 per diluted share (-2.13 a year earlier).

That is a net margin of -539.3%.

On Sanad's AAOIFI Standard 21 screen, Moderna, Inc. is currently not compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 16.2% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on July 31, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Moderna, Inc. news